Targeted inactivation of p12Cdk2ap1, CDK2 associating protein 1, leads to early embryonic lethality

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Kim, Yong ^a,b   McBride, Jim ^a   Kimlin, Lauren ^a   Pae, Eung Kwon ^a   Deshpande, Amit ^a   Wong, David T ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 2 ASSOCIATING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE G1 PHASE; CELL SURVIVAL; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; CRANIOFACIAL MALFORMATION; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; FEMALE; HOMOZYGOSITY; IMPLANTATION; IN VIVO STUDY; INCIDENCE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PREGNANCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS;

EID: 84887212444     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004518     Document Type: Article

References (45)

1. Todd R, McBride J, Tsuji T, Donoff RB, Nagai M, et al. (1995) Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. Faseb J 9: 1362-1370.
2. Tsuji T, Duh FM, Latif F, Popescu NC, Zimonjic DB, et al. (1998) Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1. J Biol Chem 273: 6704-6709.
3. Shintani S, Mihara M, Terakado N, Nakahara Y, Matsumura T, et al. (2001) Reduction of p12DOC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma. Clin Cancer Res 7: 2776-2782.
4. Kim Y, Tsuji T, Elovic A, Shintani S, Mihara M, Salih E, Kohno Y, Chin BR, Patel V, Wong DTW, Todd R (2001) Murine doc-1 cDNA cloning, sequencing and expression in normal adult tissues. Int J Oral Biol December 2001: 87-91.
5. Kim Y, McBride J, Zhang R, Zhou X, Wong DT (2005) p12(CDK2-AP1) mediates DNA damage responses induced by cisplatin. Oncogene 24: 407-418.
6. Matsuo K, Shintani S, Tsuji T, Nagata E, Lerman M, et al. (2000) p12(DOC-1), a growth suppressor, associates with DNA polymerase alpha/ primase. Faseb J 14: 1318-1324.
7. Kohno Y, Patel V, Kim Y, Tsuji T, Chin BR, et al. (2002) Apoptosis, proliferation and p12(doc-1) profiles in normal, dysplastic and malignant squamous epithelium of the Syrian hamster cheek pouch model. Oral Oncol 38: 274-280.
8. Shintani S, Ohyama H, Zhang X, McBride J, Matsuo K, et al. (2000) p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein. Mol Cell Biol 20: 6300-6307.
9. Hu MG, Hu GF, Kim Y, Tsuji T, McBride J, et al. (2004) Role of p12(CDK2-AP1) in transforming growth factor-beta1-mediated growth suppression. Cancer Res 64: 490-499.
10. Figueiredo ML, Kim Y, St John MA, Wong DT (2005) p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer. Clin Cancer Res 11: 3939-3948.
11. Peng H, Shintani S, Kim Y, Wong DT (2006) Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad signaling pathway. Neoplasia 8: 1028-1036.
12. Figueiredo ML, Dayan S, Kim Y, McBride J, Kupper TS, et al. (2006) Expression of cell-cycle regulator CDK2-associating protein 1 (p12CDK2AP1) in transgenic mice induces testicular and ovarian atrophy in vivo. Mol Reprod Dev 73: 987-997.
13. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA (2002) "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298: 597-600.
14. Sharov AA, Piao Y, Matoba R, Dudekula DB, Qian Y, et al. (2003) Transcriptome analysis of mouse stem cells and early embryos. PLoS Biol 1: E74.
15. Diederichs S, Baumer N, Schultz N, Hamra FK, Schrader MG, et al. (2005) Expression patterns of mitotic and meiotic cell cycle regulators in testicular cancer and development. Int J Cancer 116: 207-217.
16. Lee S, Lee SA, Shim C, Khang I, Lee KA, et al. (2003) Identification of estrogen-regulated genes in the mouse uterus using a delayed-implantation model. Mol Reprod Dev 64: 405-413.
17. Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926.
18. LeCouter JE, Kablar B, Whyte PF, Ying C, Rudnicki MA (1998) Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125: 4669-4679.
19. Huppert SS, Le A, Schroeter EH, Mumm JS, Saxena MT, et al. (2000) Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405: 966-970.
20. Biniszkiewicz D, Gribnau J, Ramsahoye B, Gaudet F, Eggan K, et al. (2002) Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol 22: 2124-2135.
21. Bair SR, Mellon SH (2004) Deletion of the mouse P450c17 gene causes early embryonic lethality. Mol Cell Biol 24: 5383-5390.
22. Dealy MJ, Nguyen KV, Lo J, Gstaiger M, Krek W, et al. (1999) Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E. Nat Genet 23: 245-248.
23. de Klein A, Muijtjens M, van Os R, Verhoeven Y, Smit B, et al. (2000) Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr Biol 10: 479-482.
24. Adham IM, Sallam MA, Steding G, Korabiowska M, Brinck U, et al. (2003) Disruption of the pelota gene causes early embryonic lethality and defects in cell cycle progression. Mol Cell Biol 23: 1470-1476.
25. Chen PL, Liu F, Cai S, Lin X, Li A, et al. (2005) Inactivation of CtIP leads to early embryonic lethality mediated by G1 restraint and to tumorigenesis by haploid insufficiency. Mol Cell Biol 25: 3535-3542.
26. Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB, Samarut J (1996) Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 12: 309-322.
27. Savatier P, Huang S, Szekely L, Wiman KG, Samarut J (1994) Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9: 809-818.
28. White J, Stead E, Faast R, Conn S, Cartwright P, et al. (2005) Developmental activation of the Rb-E2F pathway and establishment of cell cycle-regulated cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol Biol Cell 16: 2018-2027.
29. Conway AE, Lindgren A, Galic Z, Pyle AD, Wu H, et al. (2008) A Pluripotency and Self-Renewal Program Controls the Expansion of Genetically Unstable Cancer Stem Cells in Pluripotent Stem Cell-Derived Tumors. Stem Cells.
30. Dunker N, Krieglstein K (2000) Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur J Biochem 267: 6982-6988.
31. Weinstein M, Yang X, Deng C (2000) Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev 11: 49-58.
32. Greene RM, Pisano MM (2005) Recent advances in understanding transforming growth factor beta regulation of orofacial development. Hum Exp Toxicol 24: 1-12.
33. Dudas M, Kaartinen V (2005) Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face. Curr Top Dev Biol 66: 65-133.
34. Cwikla SJ, Tsuji T, McBride J, Wong DT, Todd R (2000) doc-1-mediated apoptosis in malignant hamster oral keratinocytes. J Oral Maxillofac Surg 58: 406-414.
35. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11-24.
36. Gallicano GI (2001) Composition, regulation, and function of the cytoskeleton in mammalian eggs and embryos. Front Biosci 6: D1089-1108.
37. Hafner M, Wenk J, Nenci A, Pasparakis M, Scharffetter-Kochanek K, et al. (2004) Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein. Genesis 38: 176-181.
38. Strothmann K, Simoni M, Mathur P, Siakhamary S, Nieschlag E, et al. (2004) Gene expression profiling of mouse Sertoli cell lines. Cell Tissue Res 315: 249-257.
39. Plikus M, Wang WP, Liu J, Wang X, Jiang TX, et al. (2004) Morpho-regulation of ectodermal organs: integument pathology and phenotypic variations in K14-Noggin engineered mice through modulation of bone morphogenic protein pathway. Am J Pathol 164: 1099-1114.
40. Ramirez A, Page A, Gandarillas A, Zanet J, Pibre S, et al. (2004) A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Genesis 39: 52-57.
41. Hay ED (1995) An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 154: 8-20.
42. Zavadil J, Bottinger EP (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774.
43. Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M, et al. (1998) Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 101: 1827-1834.
44. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, et al. (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968.
45. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, et al. (2005) Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307: 1603-1609.